FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, July 5, 2025

Tokyo's Ebola Lab Relocation Sparks Global Alarm: Orthomolecular Strategies for Biocrisis Preparedness

OMNS Commentary from Japan, with global relevance
by the Editorial Board, Orthomolecular Medicine News Service (OMNS).
In collaboration with the Japanese Society for Orthomolecular Medicine and Guardians for Health and Freedom.

(OMNS July 5, 2025) - A brewing crisis in Japan is raising alarm among physicians, scientists, and public health advocates worldwide. The Japanese government has announced plans to relocation the National Institute of Infectious Diseases, which also houses an Ebola virus research facility, from its current suburban location to densely populated center of Tokyo. Investigations reveal that the move is being executed without a clear public safety plan, or adequate emergency protocols and the move are being executed without transparent disclosure of the new site.

When questioned, local officials from Higashimurayama City-the current facility location-confirmed that no evacuation strategy exists in the event of a viral leak or bioterror incident. More troubling, they admitted that "ensuring safety is not the top priority." No convincing medical, scientific, or public health justification has been provided for conducting Ebola research in Japan at all.

Given recent history-such as the controversy over the origins of SARS-CoV-2-many fear that an accidental or deliberate release of the Ebola virus could trigger a new engineered pandemic, this time in the heart of one of the world's most populous cities. While the crisis is local, the lessons-and the risks-are global.

Why This Matters Worldwide

Orthomolecular Medicine, as pioneered by Drs. Linus Pauling and Abram Hoffer, focuses on prevention and treatment of disease using safe, natural, and nutritional means. In the face of rising biosafety concerns, Orthomolecular Medicine offers not only immune resilience-but an alternative vision for public health preparedness, grounded in nutrient sufficiency, metabolic health, and non-toxic therapeutics.

As the official publication of the Orthomolecular Medicine News Service (OMNS), we join our colleagues in Japan in calling on the global orthomolecular community to offer scientific, clinical, and public education strategies in anticipation of such biocrisis scenarios-whether in Tokyo or anywhere else.

What's Needed Now: A Five-Point Orthomolecular Preparedness Plan

The Japanese Society for Orthomolecular Medicine and Guardians for Health and Freedom are compiling an urgent preparedness protocol and request assistance from OMNS experts and readers. We invite contributions in the following five domains:

1. PREVENTION: Before Any Outbreak Occurs

Goal: Build population-wide immune resilience

• Vitamin D3: 5,000-10,000 IU/day to maintain serum 25(OH)D levels between 50-100 ng/mL
  (Note: >90% of the Japanese population is below 30 ng/mL)
• Vitamin C: 3,000-10,000 mg/day (preferably liposomal for better absorption)
• Zinc: 25-50 mg/day with 1-2 mg copper
• Selenium: 200-400 µg/day (Japanese average intake is ~100 µg)
• Magnesium: 400-1,000 mg/day (glycinate or citrate)
• B-Complex Vitamins (high-dose):
  • Thiamine (B1): 100-300 mg/day
  • Niacin (B3): 500-2,000 mg/day (instant-release preferred for immune activation)
  • Pyridoxine (B6): 50-100 mg/day
  • Cobalamin (B12): 1,000-5,000 µg/day (sublingual or methylcobalamin injection)
    High-dose B vitamins support mitochondrial function, modulate immune response, and reduce oxidative stress and inflammation.
• Quercetin: 250-500 mg twice daily as zinc ionophore and anti-inflammatory
• Melatonin: 5-10 mg nightly for immune modulation and antioxidant support

Lifestyle measures: daily sun exposure, elimination of ultra-processed foods, low carbohydrate diet, regular outdoor activity, sufficient sleep, and intermittent fasting.

2. RESPONSE: Upon First Confirmed Ebola Case in Tokyo or Elsewhere

Goal: Rapid immune mobilization and community-level awareness

• Activate public education via trusted physicians and independent health networks
• Mobilize urgent supplementation with vitamins C, D3, zinc, selenium, B-complex, and magnesium
• Begin distribution of home-use protocols and preventive checklists
• Implement H₂O₂ nebulization protocols (per Dr. Thomas Levy, 2021)

3. PROTOCOLS FOR EXPOSED BUT ASYMPTOMATIC INDIVIDUALS

Goal: Block viral replication and entry

• Vitamin C: 2-3 g every 2-3 hours orally (or liposomal)
• Vitamin D3: 50,000 IU once at time of exposure; 10,000 IU/day for 7 days
• Zinc: 50-100 mg/day short term
• Selenium: 400 µg/day
• High-dose B-complex as above, with emphasis on thiamine and niacin
• Nebulized hydrogen peroxide (1-3%), if available, under supervision

4. EARLY-STAGE ILLNESS (Pre-Hospital)

Goal: Prevent progression, support host defenses

• Vitamin C: 10-20 g/day orally or 25-50 g/day IV if accessible
• Vitamin D3: High-dose bolus (50,000 IU/day × 3 days), then maintenance
• Omega-3 EPA/DHA: ≥2 g/day
• Melatonin: up to 20 mg nightly
• High-dose B-complex, including:
  • Thiamine: up to 500 mg/day
  • Niacin: 1,000-2,000 mg/day to reduce inflammation and cytokine activity
  • B12: 5,000 µg/day or more

5. SUPPORTIVE CARE DURING HOSPITALIZATION

Goal: Reduce cytokine storm, support mitochondrial function

• IV Vitamin C: up to 1.5 g/kg/day, divided doses
• IV Thiamine: 200-500 mg/day
• IV or liposomal Glutathione: 600-1800 mg/day
• High-dose B-complex IV (if possible) or oral administration
• Vitamin D3 + K2 (MK-7): to maintain calcium balance and immune regulation
• Optional: PBMT (Photobiomodulation Therapy) + methylene blue for mitochondrial support

An Urgent Invitation to OMNS Contributors and Readers

We are calling on orthomolecular experts, clinicians, and researchers worldwide to help refine and document this preparedness plan. While the immediate threat arises in Japan, the core lessons apply globally:

• Gain-of-function research with highly lethal pathogens must be publicly scrutinized
• Orthomolecular approaches offer safe, scalable, and science-backed strategies for pandemic resilience
• Prevention is not only better than cure-it is our only realistic defense in a biocrisis

We ask: What would you recommend in your country, community, or clinic if this were happening there?

References (Selected & Preliminary)

1. Levy TE. Rapid Virus Recovery: No Need to Live in Fear. MedFox, 2021.

2. Gombart AF, et al. A Review of Micronutrients and the Immune System. Nutrients. 2020;12(1):236.

3. Grant WB, et al. Vitamin D supplementation could prevent and treat COVID-19. Nutrients. 2020;12(4):988.

4. Grant WB, et al. Vitamin D: Evidence-Based Health Benefits and Recommendations for Population Guidelines. Nutrients. 2025;17(2):277.

5. Cheng RZ. Can early and high intravenous dose of vitamin C prevent and treat COVID-19? Med Drug Discov. 2020 Mar;5:100028.

6. Lonsdale D, Marrs C. Thiamine Deficiency Disease, Dysautonomia, and High Calorie Malnutrition. Elsevier, 2017.

7. Hoffer, A., Saul, A. W., & Foster, H. D. Niacin: The real story. Basic Health Publications, 2012.

OMNS Statement

The Orthomolecular Medicine News Service affirms its commitment to independent science, public health transparency, and global collaboration in the face of rising biothreats. Nutritional immunity and non-toxic therapies are not alternative-they are essential.

To Contribute or Collaborate

Please send your recommendations, literature citations, or adapted regional protocols to:

📧 editor@orthomolecular.org
📌 Subject: Orthomolecular Biocrisis Protocol - Ebola/Japan

To subscribe to OMNS free of charge, visit:
🌐 https://orthomolecular.org/subscribe.html

Editorial Note: This article is part of a series on pandemic preparedness, nutritional medicine, and biosafety ethics. If you are a medical professional, journalist, or public health advocate and would like to republish or translate this article, permission is granted with proper citation.

Orthomolecular Medicine

Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org

Find a Doctor

To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml

The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.

Editorial Review Board:

Jennifer L. Aliano, M.S., L.Ac., C.C.N. (USA)
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Greg Beattie, Author (Australia)
Barry Breger, M.D. (Canada)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Gary S. Goldman, Ph.D. (USA)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Patrick Holford, BSc (United Kingdom)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Dwight Kalita, Ph.D. (USA)
Felix I. D. Konotey-Ahulu, M.D., FRCP (Ghana)
Peter H. Lauda, M.D. (Austria)
Fabrice Leu, N.D., (Switzerland)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Pedro Gonzalez Lombana, M.D., Ph.D. (Colombia)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Juan Manuel Martinez, M.D. (Colombia)
Mignonne Mary, M.D. (USA)
Dr.Aarti Midha M.D., ABAARM (India)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Sarah Myhill, MB, BS (United Kingdom)
Tahar Naili, M.D. (Algeria)
Zhiwei Ning, M.D., Ph.D. (China)
Zhiyong Peng, M.D. (China)
Pawel Pludowski, M.D. (Poland)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
Thomas N. Seyfried, Ph.D. (USA)
Han Ping Shi, M.D., Ph.D. (China)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Jagan Nathan Vamanan, M.D. (India)
Dr. Sunil Wimalawansa, M.D., Ph.D. (Sri Lanka)

Andrew W. Saul, Ph.D. (USA), Founding Editor
Richard Cheng, M.D., Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Editor, Spanish Edition: Sonia Rita Rial, PhD (Argentina)
Editor, German Edition: Bernhard Welker, M.D. (Germany)
Associate Editor, Arabic Edition: Ayman Kamel, DVM, MBA (Egypt)
Associate Editor, German Edition: Gerhard Dachtler, M.Eng. (Germany)
Assistant Editor: Michael Passwater (USA)
Contributing Editor: Thomas E. Levy, M.D., J.D. (USA)
Contributing Editor: Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Contributing Editor: W. Todd Penberthy, Ph.D. (USA)
Contributing Editor: Ken Walker, M.D. (Canada)
Contributing Editor: Michael J. Gonzalez, N.M.D., Ph.D. (Puerto Rico)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Associate Technology Editor: Robert C. Kennedy, M.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)

Comments and media contact: editor@orthomolecular.org OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.

To Subscribe at no charge: http://www.orthomolecular.org/subscribe.html

To Unsubscribe from this list: http://www.orthomolecular.org/unsubscribe.html